4911 Stock Overview
A biopharmaceutical company, focuses on the development and commercialization of novel botanical extraction technology and products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 4911 from our risk checks.
G&E Herbal Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$55.00 |
| 52 Week High | NT$61.40 |
| 52 Week Low | NT$48.58 |
| Beta | -0.22 |
| 11 Month Change | -5.82% |
| 3 Month Change | -1.08% |
| 1 Year Change | 2.10% |
| 33 Year Change | 111.62% |
| 5 Year Change | 53.42% |
| Change since IPO | 9.26% |
Recent News & Updates
Shareholder Returns
| 4911 | TW Personal Products | TW Market | |
|---|---|---|---|
| 7D | 0.2% | 3.6% | 2.0% |
| 1Y | 2.1% | -17.8% | 31.8% |
Return vs Industry: 4911 exceeded the TW Personal Products industry which returned -17.8% over the past year.
Return vs Market: 4911 underperformed the TW Market which returned 31.8% over the past year.
Price Volatility
| 4911 volatility | |
|---|---|
| 4911 Average Weekly Movement | 3.2% |
| Personal Products Industry Average Movement | 4.0% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.1% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4911 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4911's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 37 | Kou-Wha Kou | www.geherbs.com.tw |
G&E Herbal Biotechnology Co., Ltd., a biopharmaceutical company, focuses on the development and commercialization of novel botanical extraction technology and products. It offers botanical anti-aging cosmetic products, such as facial foam cleanser and cleansing essence, botanical extract toner, lightening lotion, essential oil, and moisturizing serum and cream; SR-100 botanical essence and bromelain illuminating cleansing mousse; and hepato protective agent capsules. The company also provides botanical healthcare products comprising ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules; and adult products.
G&E Herbal Biotechnology Co., Ltd. Fundamentals Summary
| 4911 fundamental statistics | |
|---|---|
| Market cap | NT$3.25b |
| Earnings (TTM) | NT$83.82m |
| Revenue (TTM) | NT$211.15m |
38.7x
P/E Ratio15.4x
P/S RatioIs 4911 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4911 income statement (TTM) | |
|---|---|
| Revenue | NT$211.15m |
| Cost of Revenue | NT$40.41m |
| Gross Profit | NT$170.74m |
| Other Expenses | NT$86.91m |
| Earnings | NT$83.82m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.42 |
| Gross Margin | 80.86% |
| Net Profit Margin | 39.70% |
| Debt/Equity Ratio | 0% |
How did 4911 perform over the long term?
See historical performance and comparison